Logo image of BTRS

BTRS HOLDINGS INC-CL 1 (BTRS) Stock Fundamental Analysis

USA - NASDAQ:BTRS - US11778X1046 - Common Stock

9.49 USD
-0.01 (-0.11%)
Last: 12/15/2022, 8:00:02 PM
9.49 USD
0 (0%)
After Hours: 12/15/2022, 8:00:02 PM
Fundamental Rating

2

BTRS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. The financial health of BTRS is average, but there are quite some concerns on its profitability. BTRS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BTRS has reported negative net income.
In the past year BTRS has reported a negative cash flow from operations.
BTRS Yearly Net Income VS EBIT VS OCF VS FCFBTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -20M -40M -60M

1.2 Ratios

The profitability ratios for BTRS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTRS Yearly ROA, ROE, ROICBTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -5 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BTRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTRS Yearly Profit, Operating, Gross MarginsBTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

BTRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
BTRS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BTRS is higher compared to a year ago.
BTRS Yearly Shares OutstandingBTRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 50M 100M 150M
BTRS Yearly Total Debt VS Total AssetsBTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.05 indicates that BTRS is not in any danger for bankruptcy at the moment.
BTRS's Altman-Z score of 5.05 is fine compared to the rest of the industry. BTRS outperforms 77.67% of its industry peers.
BTRS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
BTRS has a better Debt to Equity ratio (0.00) than 62.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACC10.26%
BTRS Yearly LT Debt VS Equity VS FCFBTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

BTRS has a Current Ratio of 2.15. This indicates that BTRS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BTRS (2.15) is comparable to the rest of the industry.
A Quick Ratio of 2.15 indicates that BTRS has no problem at all paying its short term obligations.
BTRS has a Quick ratio of 2.15. This is comparable to the rest of the industry: BTRS outperforms 58.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
BTRS Yearly Current Assets VS Current LiabilitesBTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BTRS have decreased strongly by -31.58% in the last year.
The Revenue has grown by 53.12% in the past year. This is a very strong growth!
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%

3.2 Future

Based on estimates for the next years, BTRS will show a small growth in Earnings Per Share. The EPS will grow by 2.45% on average per year.
Based on estimates for the next years, BTRS will show a quite strong growth in Revenue. The Revenue will grow by 18.43% on average per year.
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%

3.3 Evolution

BTRS Yearly Revenue VS EstimatesBTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BTRS Yearly EPS VS EstimatesBTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BTRS. In the last year negative earnings were reported.
Also next year BTRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTRS Price Earnings VS Forward Price EarningsBTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTRS Per share dataBTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as BTRS's earnings are expected to grow with 14.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y14.59%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BTRS HOLDINGS INC-CL 1

NASDAQ:BTRS (12/15/2022, 8:00:02 PM)

After market: 9.49 0 (0%)

9.49

-0.01 (-0.11%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2022-11-07/bmo
Earnings (Next)02-27 2023-02-27
Inst Owners0%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change0%
Market Cap1.56B
Analysts75
Price Target10.2 (7.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.28%
Min EPS beat(2)-67.7%
Max EPS beat(2)-30.85%
EPS beat(4)0
Avg EPS beat(4)-72.74%
Min EPS beat(4)-163.39%
Max EPS beat(4)-29%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)16.54%
Min Revenue beat(2)15.28%
Max Revenue beat(2)17.8%
Revenue beat(4)4
Avg Revenue beat(4)19.88%
Min Revenue beat(4)15.28%
Max Revenue beat(4)27.07%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)7.4%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.24%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.26
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB 16.68
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.15
BVpS1.53
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 5.05
F-Score2
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%
EBIT growth 1Y-68.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.16%
EBIT Next 3Y29.57%
EBIT Next 5Y15.55%
FCF growth 1Y-3547.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3371.36%
OCF growth 3YN/A
OCF growth 5YN/A